Calcium is not required for 5-lipoxygenase activity at high phosphatidyl choline vesicle concentrations

被引:25
|
作者
Skorey, KI [1 ]
Gresser, MJ [1 ]
机构
[1] Merck Frosst Canada Inc, Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Pointe Claire, PQ H9R 4P8, Canada
关键词
D O I
10.1021/bi980371g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Lipoxygenase (5-LO) catalyzes the formation of 5-hydroperoxy-eicosatetraenoic acid (5 HPETE) and leukotriene A(4) (LTA(4)) from arachidonic acid. Following a rise in intracellular calcium, 5-LO translocates to a membrane where it reacts with arachidonic acid via an 18 kD protein (FLAP). In vitro studies using a vesicle system of phosphatidylcholine (PC) and purified 5-LO were conducted under varying concentrations of PC and calcium. At high PC concentrations, 5-LO partitioned onto the vesicle containing arachidonic acid, resulting in product formation in the absence of calcium. Addition of calcium increased the initial rate of the reaction with a small increase in product accumulation. Dilution experiments in the absence of calcium at high PC concentrations indicated that binding of 5-LO to the vesicles is rapidly reversible. In the presence of calcium, this binding is much more favorable than without calcium. Stimulation of 5-LO activity by dithiothreitol (DTT) was more pronounced at high PC concentrations than at low PC concentrations. The requirement for ATP for maximal activity was independent of vesicle concentration. Inhibitors that functioned in the conditions of low PC with calcium present also inhibited under high PC without calcium. In the presence of PC and calcium and without substrate, the enzyme was unstable and was rapidly and irreversibly inactivated. In high PC without calcium, the enzyme was much more stable but it was still subject to turnover-dependent inactivation. Fluorescence energy-transfer experiments confirmed the kinetic findings that 5-LO could bind to the vesicle in the absence of calcium. These results show that in the absence of calcium, 5-LO can reversibly bind to the vesicle containing arachidonic acid and produce the same amount of product by a similar mechanism as observed with low PC and calcium. Calcium likely causes a conformational change that increases the affinity of the enzyme for the vesicle, but it is not strictly required for enzymatic activity and has no effect on the function of the catalytic site.
引用
收藏
页码:8027 / 8034
页数:8
相关论文
共 50 条
  • [21] Leukotriene B-4 costimulates 5-lipoxygenase activity in neutrophils via increased 5-lipoxygenase translocation
    Serio, KJ
    Baker, JR
    Ring, WL
    Riddick, CA
    Bigby, TD
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1997, 272 (04): : C1329 - C1334
  • [22] Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations
    Svenja D. Steinbrink
    Carlo Pergola
    Ulrike Bühring
    Sven George
    Julia Metzner
    Astrid S. Fischer
    Ann-Kathrin Häfner
    Joanna M. Wisniewska
    Gerd Geisslinger
    Oliver Werz
    Dieter Steinhilber
    Thorsten J. Maier
    Cellular and Molecular Life Sciences, 2010, 67 : 797 - 806
  • [23] Sulindac sulfide suppresses 5-lipoxygenase at clinically relevant concentrations
    Steinbrink, Svenja D.
    Pergola, Carlo
    Buehring, Ulrike
    George, Sven
    Metzner, Julia
    Fischer, Astrid S.
    Haefner, Ann-Kathrin
    Wisniewska, Joanna M.
    Geisslinger, Gerd
    Werz, Oliver
    Steinhilber, Dieter
    Maier, Thorsten J.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (05) : 797 - 806
  • [24] Arachidonic acid promotes the binding of 5-lipoxygenase on nanodiscs containing 5-lipoxygenase activating protein in the absence of calcium-ions
    Kumar, Ramakrishnan B.
    Purhonen, Pasi
    Hebert, Hans
    Jegerschold, Caroline
    PLOS ONE, 2020, 15 (07):
  • [25] Characterization of calcium and magnesium binding domains of human 5-lipoxygenase
    Bindu, PH
    Sastry, GM
    Sastry, GN
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (02) : 461 - 467
  • [26] SELECTIVE CHIRAL INHIBITORS OF 5-LIPOXYGENASE WITH ANTIINFLAMMATORY ACTIVITY
    MCMILLAN, RM
    GIRODEAU, JM
    FOSTER, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) : 501 - 503
  • [27] Suppression of 5-lipoxygenase activity by anionic cholesterol derivatives
    D. A. Aleksandrov
    G. F. Sud’ina
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2007, 1 (2) : 168 - 171
  • [28] DISULFIRAM IS A POTENT INHIBITOR OF RAT 5-LIPOXYGENASE ACTIVITY
    CHOO, LY
    RIENDEAU, D
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1987, 65 (12) : 2503 - 2506
  • [29] Suppression of 5-Lipoxygenase Activity by Anionic Cholesterol Derivatives
    Aleksandrov, D. A.
    Sud'ina, G. F.
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2007, 1 (02) : 168 - 171
  • [30] Regulation of cellular 5-lipoxygenase activity by glutathione peroxidases
    Schumann, D
    Werz, O
    Szellas, D
    Steinhilber, D
    ADVANCES IN PROSTAGLANDIN AND LEUKOTRIENE RESEARCH: BASIC SCIENCE AND NEW CLINICAL APPLICATIONS, 2001, 16 : 21 - 23